AAAAAA

   
Results: 1-8 |
Results: 8
PROGNOSTIC VALUE OF QUANTITATIVE CYTOMETRY IN A SERIES OF 415 T1T2 N0N1/M0 BREAST-CANCER PATIENTS - PRELIMINARY-RESULTS/
Authors: BOLLA M SEIGNEURIN D WINCKEL P MARRONCHARRIERE J PANH MH PASQUIER D CHEDIN M PAYAN R MERLIN F COLONNA M
Citation: M. Bolla et al., PROGNOSTIC VALUE OF QUANTITATIVE CYTOMETRY IN A SERIES OF 415 T1T2 N0N1/M0 BREAST-CANCER PATIENTS - PRELIMINARY-RESULTS/, European journal of cancer, 32A(10), 1996, pp. 1680-1685
PROTEIN-TYROSINE KINASE-ACTIVITY IN 350 T1 T2, N0/N1 BREAST-CANCER - PRELIMINARY-RESULTS/
Authors: BOLLA M ROSTAINGPUISSANT B BOTTARI SP CHEDIN M MARRONCHARRIERE J COLONNA M BERLAND E CHAMBAZ E
Citation: M. Bolla et al., PROTEIN-TYROSINE KINASE-ACTIVITY IN 350 T1 T2, N0/N1 BREAST-CANCER - PRELIMINARY-RESULTS/, Breast cancer research and treatment, 39(3), 1996, pp. 327-334
PROGNOSTIC VALUE OF QUANTITATIVE CYTOMETR Y IN A SERIE OF 415 T1T2 NON1/MO BREAST CANCERS/
Authors: BOLLA M SEIGNEURIN D WINCKEL P MARRONCHARRIERE J PANH MH PASQUIER D CHEDIN M PAYAN R MERLIN F VENDITTI V
Citation: M. Bolla et al., PROGNOSTIC VALUE OF QUANTITATIVE CYTOMETR Y IN A SERIE OF 415 T1T2 NON1/MO BREAST CANCERS/, Bulletin du cancer, 83(9), 1996, pp. 687-692
PROTEIN-TYROSINE KINASE-ACTIVITY IN 350 T1 T2, N0/N1 BREAST-CANCER - PRELIMINARY-RESULTS/
Authors: BOLLA M ROSTAINGPUISSANT B BOTTARI SP CHEDIN M MARRONCHARRIERE J COLONNA M BERLAND E CHAMBAZ EM
Citation: M. Bolla et al., PROTEIN-TYROSINE KINASE-ACTIVITY IN 350 T1 T2, N0/N1 BREAST-CANCER - PRELIMINARY-RESULTS/, European journal of cancer, 31A, 1995, pp. 649-649
TAMOXIFEN ADJUVANT HORMONAL TREATMENT ACCORDING TO PROGNOSTIC FACTORS- SHORT-TERM RESULTS OF A SERIES OF 695 T1 T2 N0 N1 BREAST CARCINOMAS/
Authors: BOLLA M MOUSSEAU M WINCKEL P MARRONCHARRIERE J COLONNA M PASQUIER D CHEDIN M PANH MH
Citation: M. Bolla et al., TAMOXIFEN ADJUVANT HORMONAL TREATMENT ACCORDING TO PROGNOSTIC FACTORS- SHORT-TERM RESULTS OF A SERIES OF 695 T1 T2 N0 N1 BREAST CARCINOMAS/, European journal of cancer, 31A, 1995, pp. 656-656
LACK OF PROGNOSTIC VALUE OF EPIDERMAL GROWTH-FACTOR RECEPTOR IN A SERIES OF 229 T1 T2, N0/N1 BREAST CANCERS, WITH WELL-DEFINED PROGNOSTIC PARAMETERS/
Authors: BOLLA M CHEDIN M COLONNA M MARRONCHARRIERE J ROSTAINGPUISSANT B PASQUIER D PANH MH WINCKEL P CHAMBAZ EM
Citation: M. Bolla et al., LACK OF PROGNOSTIC VALUE OF EPIDERMAL GROWTH-FACTOR RECEPTOR IN A SERIES OF 229 T1 T2, N0/N1 BREAST CANCERS, WITH WELL-DEFINED PROGNOSTIC PARAMETERS/, Breast cancer research and treatment, 29(3), 1994, pp. 265-270
MODULATION OF THE INDICATIONS OF ADJUVANT HORMONAL TREATMENT BY TAMOXIFEN IN T1T2 N0N1 BREAST CARCINOMAS - PRELIMINARY-RESULTS OF A MULTICENTRIC STUDY INCLUDING 695 CASES/
Authors: BOLLA M MOUSSEAU M WINCKEL P MARRONCHARRIERE J COLONNA M PASQUIER D CHEDIN M PANH MH SEIGNEURIN D SALVAT J SAGE JC FROGET G SCHAERER R VROUSOS C
Citation: M. Bolla et al., MODULATION OF THE INDICATIONS OF ADJUVANT HORMONAL TREATMENT BY TAMOXIFEN IN T1T2 N0N1 BREAST CARCINOMAS - PRELIMINARY-RESULTS OF A MULTICENTRIC STUDY INCLUDING 695 CASES/, Bulletin du cancer, 81(12), 1994, pp. 1085-1090
PROTEIN-TYROSINE KINASE-ACTIVITY AS A PROGNOSTIC PARAMETER IN BREAST-CANCER - A PILOT-STUDY
Authors: BOLLA M ROSTAINGPUISSANT B CHEDIN M SOUVIGNET C MARRONCHARRIERE J COLONNA M BERLAND E CHAMBAZ EM
Citation: M. Bolla et al., PROTEIN-TYROSINE KINASE-ACTIVITY AS A PROGNOSTIC PARAMETER IN BREAST-CANCER - A PILOT-STUDY, Breast cancer research and treatment, 26(3), 1993, pp. 283-287
Risultati: 1-8 |